Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety and efficacy of Angiomax as an alternative
anticoagulant to heparin with protamine reversal in patients undergoing off-pump coronary
artery bypass graft surgery.